Suppr超能文献

普鲁士蓝的长期稳定性研究——水分含量和铊结合的质量评估

Long-term stability study of Prussian blue - a quality assessment of water content and thallium binding.

作者信息

Mohammad Adil, Faustino Patrick J, Khan Mansoor A, Yang Yongsheng

机构信息

Food and Drug Administration, Center for Drug Evaluation and Research, Office of Testing and Research, Division of Product Quality Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.

Food and Drug Administration, Center for Drug Evaluation and Research, Office of Testing and Research, Division of Product Quality Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.

出版信息

Int J Pharm. 2014 Dec 30;477(1-2):122-7. doi: 10.1016/j.ijpharm.2014.10.020. Epub 2014 Oct 11.

Abstract

The purpose of this study is to assess the long-term stability of Prussian blue (PB) drug product (DP) and active pharmaceutical ingredient (API) under laboratory storage conditions by monitoring the loss in water content and the corresponding change of the in vitro thallium binding capacity that represents product performance. The bound water content and the in vitro thallium binding capacity of PB DPs and APIs were measured in 2003 and 2013, respectively. Water content, a critical quality attribute that directly correlates to the thallium (Tl) binding capacity was measured by thermal gravimetric analysis (TGA). The thallium binding study was conducted by testing PB in buffered solutions over the human gastrointestinal pH range with thallium concentrations ranging from 600 to 1,500 ppm. Samples were incubated at physiological temperature of 37°C in a shaking water bath to mimic gastric flux and intestinal transport. The binding equilibrium was reached at 24h. Following incubation, each sample was filtered and the free thallium was analyzed using a validated inductively coupled plasma spectroscopic method (ICP). The Langmuir isotherm was plotted to calculate maximum binding capacity (MBC). Compared with 2003, the water content of DP-1 decreased by about 14.1% (from 15.6 to 13.4 mol), and the MBC of DP-1 decreased by about 12.5% (from 714 to 625 mg/g) at pH 7.5. When low concentration of thallium (600 ppm) was used at pH 7.5, the Tl binding remained comparable for both API-1 (286 vs 276 mg/g) and DP-1 (286 vs 268 mg/g). Similarly, the Tl binding remained unchanged for both API-1 (237 vs 255 mg/g) and DP-1 (234 vs 236 mg/g) at pH 5.0. However, at pH 1.0 the binding was reduced 32.3% and 25.9% for API-1 and DP-1, respectively. Since the majority of binding takes place in the upper GI tract where pH around 5 can be expected, and therefore, the Tl binding capacity of PB should be comparable for new and aged samples. The findings that Tl binding changes with the water loss of PB and pH conditions are consistent with our previously published data. The study also represents the first quantitative assessment of the long-term stability of PB. Over last 10 years, PB DPs and APIs have lost about 20% water under ambient laboratory storage conditions which are consistent with a controlled warehouse environment. While the maximum binding capacity of PB to thallium was decreased after about 10 years of long-term storage, it is still very effective, suggesting that the shelf life of PB should be much longer than the manufacturer ascribed expiration date of 2008 under proper storage conditions.

摘要

本研究的目的是通过监测水分含量的损失以及代表产品性能的体外铊结合能力的相应变化,评估普鲁士蓝(PB)药品(DP)和活性药物成分(API)在实验室储存条件下的长期稳定性。分别于2003年和2013年测量了PB DP和API的结合水含量和体外铊结合能力。水分含量是与铊(Tl)结合能力直接相关的关键质量属性,通过热重分析(TGA)进行测量。铊结合研究是通过在人胃肠道pH范围内的缓冲溶液中测试PB进行的,铊浓度范围为600至1500 ppm。样品在37°C的生理温度下于振荡水浴中孵育,以模拟胃蠕动和肠道转运。24小时达到结合平衡。孵育后,每个样品进行过滤,使用经过验证的电感耦合等离子体光谱法(ICP)分析游离铊。绘制朗缪尔等温线以计算最大结合能力(MBC)。与2003年相比,DP - 1的水分含量下降了约14.1%(从15.6降至13.4摩尔),在pH 7.5时DP - 1的MBC下降了约12.5%(从714降至625 mg/g)。当在pH 7.5使用低浓度铊(600 ppm)时,API - 1(286对276 mg/g)和DP - 1(286对268 mg/g)的Tl结合保持相当。同样,在pH 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验